Expanding the Metabolic Pipeline Ascletis plans to develop ASC35 both as a monotherapy and in combinations for obesity, diabetes, and metabolic dysfunction-associated steatohepatitis (MASH)
However, the semaglutide base compound is FDA-approved, and all PlexusDx medications are produced under strict pharmaceutical compounding standards
More GLP-1 was needed to have the same biological effect, meaning they were resistant to GLP-1." This switch around was so unexpected, the researchers ran further tests on mouse models with the PAM gene deactivated
However, this did not offset the high spending on brand-name drugs, as generics made up only 8% of overall prescription spending despite making up 90% of filled prescriptions in the U.S
Funding This work was supported by the National Natural Science Foundation of China (NSFC82173532, NSFCU20A20350, NSFC81971455, NSFC81871216 and NSFC81601345), the Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (gxyq2021173), the Postdoctoral Research Foundation of China (2021M700181), the University Natural Science Research Project of Anhui Province (KJ2020A0203), the National Key Research and Development Program (2018YFC1004201, 2016YFC1000204)
